The Magazine for Sleep Professionals
Wednesday, October 21, 2026
Nyxoah SA announced that the U.S. Food and Drug Administration (FDA) has approved the Genio system (hypoglossal nerve stimulation) for a subset of patients with moderate to severe OSA with an Apnea-Hypopnea Index (AHI) of greater than or equal to 15 and less than or equal to 65. Genio is […]
Fisher & Paykel Healthcare is launching a new advertising campaign called ‘Powered by Curiosity’, which highlights the performance of the company’s full-face masks for treating obstructive sleep apnea. After recent new product launches in the nasal and nasal pillows category (F&P Solo™ and F&P Nova Micro™), this campaign focuses on […]
Nxera Pharma Co., Ltd. today announces that it will receive US$4.8 million in milestone payments from Centessa Pharmaceuticals pursuant to its research collaboration with Centessa. The milestones were achieved as Centessa initiated clinical development of ORX142, its second novel orexin receptor 2 (OX2R) agonist, following the recent clearance of an […]
Compumedics Limited is excited to announce the launch of the Falcon, a Home Sleep Testing device now available for sale in the United States. The Falcon is designed to be simple to set up and deploy, enhancing both patient experience and workflow efficiency in home sleep testing. The Falcon HST […]
Sleep labs and suppliers across the U.S. are bracing for the economic ripple effects of sweeping new tariffs on imported goods. Consider, for example, a typical sleep diagnostic test. It might consist of a small machine, a box with plastic casing that houses electronics. Many of its components—the plastic or […]
Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, today unveiled EmbraceMini, its revolutionary new wearable for clinical trials. EmbraceMini is an ultra-compact health monitoring device, focused on delivering exceptional wearability and high-quality data without compromising sponsor or participant needs. With its incredibly small footprint and […]
EnsoData, an innovator in AI healthtech solutions, announced a $20 million Series B financing led by Questa Capital. This new capital will enable EnsoData to accelerate adoption of its AI-powered sleep medicine solutions, improving the sleep care pathway for, in the US alone, an estimated 54 million patients suffering from […]
Nihon Kohden, a global leader in medical device innovation for high-precision patient monitoring and diagnostics, proudly announces the launch of its second-generation Live View Panel Pro™, a specialized virtual health system designed to transform remote neurophysiological assessment and treatment. The upgraded platform combines real-time interactive viewing, integrated two-way intercom and […]
ProSomnus Sleep Technologies announces EVO Guided. EVO Guided is a new precision, custom oral device for the treatment of Obstructive Sleep Apnea (“OSA”). FDA cleared, patented and covered by most medical insurances, EVO Guided is the first oral device bioengineered to dilate the oropharynx and the velopharynx for optimal therapeutic […]
Harmony Biosciences Holdings, Inc., today announced a settlement agreement with Lupin Limited, resolving the patent infringement litigation related to Lupin’s Abbreviated New Drug Application (ANDA) for a generic version of WAKIX® (pitolisant hydrochloride). As part of the agreement, litigation in the United States District Court for the District of Delaware will […]
